Source: PR NEWSWIRE

Press Release: Agensys : Antibody Drug Conjugate Market Opportunity Analysis

MUMBAI, May 21, 2014 /PRNewswire/ -- Ever since the first attempt in the 1980s to use antibody based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Sef Kurstjens's photo - President & CEO of Agensys

President & CEO

Sef Kurstjens

CEO Approval Rating

68/100

Read more